These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 24106924)
1. Effect of prucalopride on symptoms of chronic constipation. Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924 [TBL] [Abstract][Full Text] [Related]
2. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride. Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251 [TBL] [Abstract][Full Text] [Related]
3. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief. Pennant M; Orlando R; Barton P; Bayliss S; Routh K; Meads C Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652 [TBL] [Abstract][Full Text] [Related]
4. Prucalopride: a review of its use in the management of chronic constipation. Keating GM Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435 [TBL] [Abstract][Full Text] [Related]
5. [Some practical questions on chronic stipsis treatment with prucalopride]. Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393 [TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation. Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials. Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037 [TBL] [Abstract][Full Text] [Related]
10. A placebo-controlled trial of prucalopride for severe chronic constipation. Camilleri M; Kerstens R; Rykx A; Vandeplassche L N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating. Staller K; Hinson J; Kerstens R; Spalding W; Lembo A Am J Gastroenterol; 2022 Jan; 117(1):184-188. PubMed ID: 34585675 [TBL] [Abstract][Full Text] [Related]
12. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis. Emmanuel A; Cools M; Vandeplassche L; Kerstens R Am J Gastroenterol; 2014 Jun; 109(6):887-94. PubMed ID: 24732867 [TBL] [Abstract][Full Text] [Related]
13. Prucalopride succinate for the treatment of constipation: an update. Bassotti G; Gambaccini D; Bellini M Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation. Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949 [TBL] [Abstract][Full Text] [Related]
15. Prucalopride for the treatment of constipation: a view from 2015 and beyond. Bassotti G; Usai Satta P; Bellini M Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758 [TBL] [Abstract][Full Text] [Related]
16. Use of prucalopride in adults with chronic idiopathic constipation. Vijayvargiya P; Camilleri M Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799 [No Abstract] [Full Text] [Related]
17. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride. Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103 [TBL] [Abstract][Full Text] [Related]
20. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial. Coremans G; Kerstens R; De Pauw M; Stevens M Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]